CD4 and rheumatoid arthritis: Variations in patient responses are influenced by B-cell turnover [45], and a link between the RTX levels, CD4+ count, and DAS28 in patients with RA has been observed, with CD4+ count decrease correlating with better clinical outcomes [46].